|
|
Volumn 255, Issue 8, 2008, Pages 1266-1267
|
|
Levodopa reduces risk factors for vascular disease in parkinsonian patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DECARBOXYLASE INHIBITOR;
DOPAMINE;
LEVODOPA;
BLOOD PRESSURE MEASUREMENT;
DRUG MEGADOSE;
HOMOCYSTINURIA;
HOSPITALIZATION;
HUMAN;
LABORATORY TEST;
LETTER;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RISK FACTOR;
RISK REDUCTION;
UNSPECIFIED SIDE EFFECT;
VASCULAR DISEASE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIPARKINSON AGENTS;
BLOOD GLUCOSE;
BLOOD PRESSURE;
CHOLESTEROL;
FEMALE;
HUMANS;
LEVODOPA;
LIPID METABOLISM;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
RETROSPECTIVE STUDIES;
RISK FACTORS;
VASCULAR DISEASES;
|
|
EID: 60049099580
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-0869-8 Document Type: Letter |
|
Times cited : (4)
|
|
References (15)
|
